US FDA approves Basilea Pharmaceutica's antibiotic
==========

The U.S. Food and Drug Administration (FDA) has approved Basilea Pharmaceutica's antibiotic ceftobiprole for the treatment of bacterial infections, including multidrug-resistant strains. The Switzerland-based company sought approval for the treatment of Staphylococcus aureus bacteremia, acute bacterial skin and skin structure infections, and community-acquired bacterial pneumonia. The approval provides additional options for patients who have developed resistance to currently available antibiotics. The antibiotic, sold under the brand name Zevtera, is an advanced-generation cephalosporin antibiotic that works against a wide range of Gram-positive and Gram-negative bacteria, including methicillin-resistant strains.

#Fda #BasileaPharmaceutica #Antibiotic #Ceftobiprole #BacterialInfections #MultidrugresistantStrains #StaphylococcusAureusBacteremia #AcuteBacterialSkinAndSkinStructureInfections #CommunityacquiredBacterialPneumonia #GrampositiveBacteria #GramnegativeBacteria #MethicillinresistantStrains

https://www.investing.com/news/economy/us-fda-approves-basilea-pharmaceuticas-antibiotic-3364318